Communiqués Vistin Pharma ASA

Actions

VISTN

NO0010734122

Produits pharmaceutiques

Marché Fermé - Oslo Bors 16:45:00 21/09/2026			Varia. 5j.	Varia. 1 janv.
18,50 ^NOK	-2,12%		-2,63%	-11,06%

20/08	Vistin Pharma ASA publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
20/08	Transcript : Vistin Pharma ASA, Q2 2026 Earnings Call, Aug 20, 2026

Communiqués

20/08	Vistin Pharma ASA: Second quarter and YTD 2026 financial results	GL
13/08	Vistin Pharma ASA: Invitation to Q2 2026 conference call	GL
22/05	Ex dividend NOK 1.00 today	GL
20/05	Vistin Pharma ASA: Minutes from the annual general meeting 2026	GL
08/05	Vistin Pharma : Redeye Theme Event – Diabetes 2026	PU
28/04	Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026	GL
27/04	Vistin Pharma ASA: First quarter 2026 financial results	AQ
27/04	Vistin Pharma : Annual Report 2025	PU
24/04	2025 Annual Report Vistin Pharma ASA	AQ
24/04	2025 Annual Report Vistin Pharma ASA	GL
24/04	Vistin Pharma ASA: First quarter 2026 financial results	GL
17/04	Vistin Pharma ASA: Invitation to Q1 2026 conference call	GL
30/03	Vistin Pharma : DNB Carnegie SMB Conference 26. March 2026	PU
20/02	Vistin Pharma ASA: Mandatory notification of trade	GL
13/02	Vistin Pharma ASA, Fourth quarter and preliminary 2025 financial results	AQ
12/02	Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend	GL
12/02	Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results	GL
05/02	Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call	GL
08/12	Vistin Pharma : Finansiell kalender	PU
31/10/25	Vistin Pharma ASA: Third quarter and YTD 2025 financial results	GL
24/10/25	Vistin Pharma ASA: Invitation to Q3 2025 conference call	GL
15/08/25	Vistin Pharma ASA: Second quarter and YTD 2025 financial results	GL
11/08/25	Vistin Pharma ASA: Invitation to Q2 2025 conference call	AQ
08/08/25	Vistin Pharma ASA: Invitation to Q2 2025 conference call	GL
04/06/25	Ex dividend NOK 1.25 today	GL